JP2017055769A5 - - Google Patents

Download PDF

Info

Publication number
JP2017055769A5
JP2017055769A5 JP2016252390A JP2016252390A JP2017055769A5 JP 2017055769 A5 JP2017055769 A5 JP 2017055769A5 JP 2016252390 A JP2016252390 A JP 2016252390A JP 2016252390 A JP2016252390 A JP 2016252390A JP 2017055769 A5 JP2017055769 A5 JP 2017055769A5
Authority
JP
Japan
Prior art keywords
breast cancer
level
ube2c
rna
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016252390A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017055769A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2017055769A publication Critical patent/JP2017055769A/ja
Publication of JP2017055769A5 publication Critical patent/JP2017055769A5/ja
Pending legal-status Critical Current

Links

JP2016252390A 2011-11-08 2016-12-27 乳癌の予後を予測する方法 Pending JP2017055769A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161557238P 2011-11-08 2011-11-08
US61/557,238 2011-11-08
US201261597426P 2012-02-10 2012-02-10
US61/597,426 2012-02-10

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2014540131A Division JP6147755B2 (ja) 2011-11-08 2012-11-02 乳癌の予後を予測する方法

Publications (2)

Publication Number Publication Date
JP2017055769A JP2017055769A (ja) 2017-03-23
JP2017055769A5 true JP2017055769A5 (https=) 2017-08-10

Family

ID=48290467

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014540131A Active JP6147755B2 (ja) 2011-11-08 2012-11-02 乳癌の予後を予測する方法
JP2016252390A Pending JP2017055769A (ja) 2011-11-08 2016-12-27 乳癌の予後を予測する方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2014540131A Active JP6147755B2 (ja) 2011-11-08 2012-11-02 乳癌の予後を予測する方法

Country Status (9)

Country Link
US (4) US20140296085A1 (https=)
EP (1) EP2776830B1 (https=)
JP (2) JP6147755B2 (https=)
AU (1) AU2012336120B2 (https=)
CA (1) CA2854805C (https=)
IL (4) IL232445B (https=)
MX (1) MX357402B (https=)
SG (2) SG10202010758SA (https=)
WO (1) WO2013070521A1 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030198972A1 (en) 2001-12-21 2003-10-23 Erlander Mark G. Grading of breast cancer
US9856533B2 (en) 2003-09-19 2018-01-02 Biotheranostics, Inc. Predicting breast cancer treatment outcome
CN103998064A (zh) 2010-12-09 2014-08-20 生物诊断治疗公司 治疗后的乳腺癌预后
WO2014044724A1 (en) * 2012-09-18 2014-03-27 Qiagen Gmbh Method and kit for preparing a target rna depleted sample
US10487362B2 (en) * 2013-01-09 2019-11-26 Health Research, Inc. Methods for diagnosing cancer based on small nucleolar RNA HBII-52
WO2014130444A1 (en) * 2013-02-19 2014-08-28 Genomic Health, Inc. Method of predicting breast cancer prognosis
BR112016005225B1 (pt) * 2013-09-11 2023-11-14 Bio Theranostics, Inc Métodos para avaliar câncer de mama em um indivíduo
US20160259881A1 (en) * 2013-10-29 2016-09-08 Genomic Health, Inc. Methods of incorporation of transcript chromosomal locus information for identification of biomarkers of disease recurrence risk
CN105214077B (zh) * 2014-06-03 2019-02-05 浙江阿思科力生物科技有限公司 Usp33在肿瘤中的应用
WO2016094330A2 (en) * 2014-12-08 2016-06-16 20/20 Genesystems, Inc Methods and machine learning systems for predicting the liklihood or risk of having cancer
JP6932080B2 (ja) * 2014-12-10 2021-09-08 コーニンクレッカ フィリップス エヌ ヴェＫｏｎｉｎｋｌｉｊｋｅ Ｐｈｉｌｉｐｓ Ｎ．Ｖ． 非コード−コード遺伝子共発現ネットワークを生成する方法及びシステム
JP6876680B2 (ja) 2015-09-01 2021-05-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 ネオモルフィックｓｆ３ｂ１変異体に関連するスプライスバリアント
EP3365000B1 (en) 2015-10-23 2020-06-10 Novartis AG Method of deriving a value for percent biomarker positivity for selected cells present in a field of view
WO2017083675A1 (en) 2015-11-13 2017-05-18 Biotheranostics, Inc. Integration of tumor characteristics with breast cancer index
EP3202913B1 (en) * 2016-02-08 2019-01-30 King Faisal Specialist Hospital And Research Centre A set of genes for use in a method of predicting the likelihood of a breast cancer patient's survival
CA3063450A1 (en) * 2017-05-19 2018-11-22 Lunella Biotech, Inc. Companion diagnostics for mitochondrial inhibitors
US20190376115A1 (en) * 2018-06-08 2019-12-12 Glympse Bio, Inc. Activity sensor design
CN108893537B (zh) * 2018-07-19 2020-10-30 青岛泱深生物医药有限公司 C7orf70及其应用
JP2020028278A (ja) * 2018-08-24 2020-02-27 国立大学法人九州大学 被検体に生じるイベントを予測するための判別器の生成方法、及び前記判別器を用いた被検体の層別化方法
CN113748215B (zh) * 2018-11-04 2024-07-23 Pfs基因组学公司 用于乳腺癌的预后和预测来自辅助放射疗法的益处的方法和基因组分类器
CN109859801B (zh) * 2019-02-14 2023-09-19 辽宁省肿瘤医院 一种含有七个基因作为生物标志物预测肺鳞癌预后的模型及建立方法
US11211144B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Methods and systems for refining copy number variation in a liquid biopsy assay
US11211147B2 (en) 2020-02-18 2021-12-28 Tempus Labs, Inc. Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
US11475981B2 (en) 2020-02-18 2022-10-18 Tempus Labs, Inc. Methods and systems for dynamic variant thresholding in a liquid biopsy assay
US20240218448A1 (en) * 2020-04-23 2024-07-04 Board Of Regents, The University Of Texas System Methods and compositions related to full-length excised intron rnas (flexi rnas)
JP2023542867A (ja) 2020-09-11 2023-10-12 グリンプス バイオ， インコーポレイテッド 疾患の検出／診断、病期分類、モニタリング及び処置のための生体外でのプロテアーゼ活性検出
RU2763839C1 (ru) * 2021-04-27 2022-01-11 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр онкологии имени Н.Н. Петрова" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ онкологии им. Н.Н. Петрова" Минздрава России) Способ многофакторного прогноза рака молочной железы
CN113667749A (zh) * 2021-08-03 2021-11-19 广东省人民医院 四个关键基因组合评估乳腺癌风险的诊断试剂盒
CN114480650A (zh) * 2022-02-08 2022-05-13 深圳市陆为生物技术有限公司 一种预测三阴乳腺癌临床预后复发风险的标志物及模型
CN114657242B (zh) * 2022-03-16 2022-11-11 广州医科大学附属第一医院 Gpr33基因在马尔尼菲篮状菌易感人群评估的应用
CN121137157B (zh) * 2025-11-17 2026-02-10 长春科技学院 一种评估上皮性卵巢癌复发风险的试剂的用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2374311T3 (es) * 2002-03-13 2012-02-15 Genomic Health, Inc. Obtención de perfil de expresión génica en tejidos tumorales biopsiados.
US20040231909A1 (en) * 2003-01-15 2004-11-25 Tai-Yang Luh Motorized vehicle having forward and backward differential structure
WO2005001138A2 (en) * 2003-06-18 2005-01-06 Arcturus Bioscience, Inc. Breast cancer survival and recurrence
AU2004258085B2 (en) * 2003-07-10 2010-05-27 Genomic Health, Inc. Expression profile algorithm and test for cancer prognosis
JP2005270093A (ja) * 2004-02-24 2005-10-06 Nippon Medical School 乳癌の術後予後予測に関与する遺伝子
EP1797429A2 (en) * 2004-09-30 2007-06-20 Bayer HealthCare AG Methods and kits for the prediction of therapeutic success and recurrence free survival in cancer therapy
EP2061885A4 (en) * 2006-09-15 2011-03-09 Univ Mcgill STROMA-DERIVED PREDICTOR FOR BREAST CANCER
WO2008079269A2 (en) * 2006-12-19 2008-07-03 Genego, Inc. Novel methods for functional analysis of high-throughput experimental data and gene groups identified therfrom
EP2036988A1 (en) * 2007-09-12 2009-03-18 Siemens Healthcare Diagnostics GmbH A method for predicting the response of a tumor in a patient suffering from or at risk of developing recurrent gynecologic cancer towards a chemotherapeutic agent
WO2009071655A2 (en) * 2007-12-06 2009-06-11 Siemens Healthcare Diagnostics Inc. Methods for breast cancer prognosis
US20110020370A1 (en) * 2008-12-11 2011-01-27 Elias Georges Slc7a5 directed diagnostics and therapeutics for neoplastic disease
CN101851611A (zh) * 2009-04-01 2010-10-06 天津医科大学附属肿瘤医院 驱动蛋白样蛋白kif1b的转移相关功能和预测肿瘤患者预后的标志物用途及其应用方法
WO2010127399A1 (en) * 2009-05-06 2010-11-11 Walter And Eliza Hall Institute Of Medical Research Gene expression profiles and uses thereof
US20120309640A1 (en) * 2009-10-08 2012-12-06 Torti Frank M Diagnostic and Prognostic Markers for Cancer
MX337650B (es) * 2009-11-23 2016-03-14 Genomic Health Inc Metodos para predecir el desenlace clinico del cancer.
WO2011068839A1 (en) * 2009-12-01 2011-06-09 Compendia Bioscience, Inc. Classification of cancers
GB0922437D0 (en) * 2009-12-22 2010-02-03 Cancer Rec Tech Ltd Hypoxia tumour markers
US20130143753A1 (en) * 2010-03-01 2013-06-06 Adelbio Methods for predicting outcome of breast cancer, and/or risk of relapse, response or survival of a patient suffering therefrom
EP2845911B1 (en) * 2010-03-31 2016-05-18 Sividon Diagnostics GmbH Method for breast cancer recurrence prediction under endocrine treatment

Similar Documents

Publication Publication Date Title
JP2017055769A5 (https=)
Bach et al. Long noncoding RNAs in cancer cells
JP2010538609A5 (https=)
JP2020031642A5 (https=)
JP2016174600A5 (https=)
Ahadi Functional roles of lncRNAs in the pathogenesis and progression of cancer
Lin et al. Increased expression of long noncoding RNA ABHD11-AS1 in gastric cancer and its clinical significance
JP2014532428A5 (https=)
JP2016214245A5 (https=)
UA110790C2 (uk) Спосіб передбачування рецидиву раку молочної залози при ендокринному лікуванні
JP2009523028A5 (https=)
JP2019524884A5 (https=)
EP4428157A3 (en) Use of immune cell-specific gene expression for prognosis of prostate cancer and prediction of responsiveness to radiation therapy
JP2016509833A5 (https=)
NZ593228A (en) Gene expression markers (inhba) for colorectal cancer prognosis
Sun et al. Clinical significance of the decreased expression of hsa_circ_001242 in oral squamous cell carcinoma
JP2018527886A5 (https=)
WO2010118166A3 (en) Methods of predicting cancer risk using gene expression in premalignant tissue
JP2016537010A5 (https=)
JP2012513216A5 (https=)
JP2016533708A5 (https=)
EP4427804A3 (en) Methods of diagnosing cancer
JP2017195803A5 (https=)
EA201290107A1 (ru) Способ определения пациента как восприимчивого или не восприимчивого к иммунотерапии
EP2687609A3 (en) Method for treating solid tumor